|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 08, 2016 ) Browse 70 market data Tables and 75 Figures spread through 144 Pages and in-depth TOC on "Label-Free Detection Market"
http://www.marketsandmarkets.com/Market-Reports/label-free-detection-market-32435593.html
Early buyers will receive 10% customization on this report.
This report studies the global label-free detection market over the forecast period of 2015 to 2020. This market is valued at an estimated USD 1.22 Billion in 2015 and expected to grow at a CAGR of 11.86% between 2015 and 2020, to reach USD 2.13 Billion in 2020.
The report segments this market by technology, application, product, and geography. The technology segments included in this report are bio-layer interferometry (BLI), cellular dielectric spectroscopy, optical waveguide grating technology (OWG), surface plasmon resonance (SPR), and other technologies.
Download the PDF Brochure For FREE@
http://www.marketsandmarkets.com/pdfdownload.asp?id=32435593
Of these, the surface plasmon resonance technology segment commanded the largest share of the global label-free detection market in 2015 and is also poised to grow at the healthy CAGR between 2015 and 2020. However, bio-layer interferometry segment is will grow at the highest CAGR between 2015 and 2020. The advantage of not using any labels or reporter molecules for detection along with increasing application of biomolecular interaction analysis in drug discovery are driving the growth of this technology segment.
The application segments included in this report are binding kinetics, binding thermodynamics, endogenous receptor detection, hit confirmation, lead generation, and other application segments. The binding kinetics application segment commanded the largest share of the global label-free detection market in 2015, while the hit confirmation segment is poised to grow at the highest CAGR between 2015 and 2020. The binding kinetic studies measure drug residence time, which are important for predicting clinical outcome of drug candidates. As such, the development in drug discovery will boost the binding kinetics studies and drive the label-free detection market.
Get The Sample Copy Of This Report:
http://www.marketsandmarkets.com/requestsample.asp?id=32435593
The product segments in this report are instruments and consumables. Of these, the instrument segment commanded the largest share of the global label-free detection market in 2015 and is also poised to grow at the healthy CAGR between 2015 and 2020. Enhanced instrumentation makes it possible for pharmaceutical and biotechnology companies to streamline and simplify laboratory workflows, improve productivity and leads to reduction in the costs. Increasing adoption of label-free detection technologies in drug discovery will boost the growth of instruments in the forecast period.
Based on geography, the global label-free detection market is segmented into geographic segments of Asia, Europe, North America, and the Rest of the World (RoW).
Label-free detection is a very well accepted drug discovery tool in the pharmaceutical & biotech industry and academic research. It helps in the investigation of biomolecular interactions without auto-fluorescent, spatial-interference, or quenching effects of labels. Increasing drug discovery programs by pharmaceutical companies and academic institutes will drive the growth of this market between 2015 and 2020. However, increasing market consolidation and high cost of instruments and consumables will restrain the growth of this market
The major players in the label-free detection market are Ametek, Inc. (U.S.), Attana AB (Sweden), Bio-Rad Laboratories, Inc. (U.S.), BiOptix (USA), Corning, Inc. (U.S.), Danaher Corporation (U.S.), General Electric Corporation (U.S.), Pall Corporation (U.S.), PerkinElmer (U.S.), and Roche (Switzerland).
About MarketsandMarkets:
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.
M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Subscribe Reports from Healthcare Domain @ http://www.marketsandmarkets.com/Knowledgestore.asp
Contact:
Mr. Rohan
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Telephone No : 1-888-600-6441
MarketsandMarkets
Mr. Rohan
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
